ESR1 and glioblastoma: Taking into account that unliganded estrogen receptor-α is an effector of MAPK signaling and that Ang II is able to activate the MAPK pathway via Janus-kinase, we investigated whether Ang II is able to induce transactivation of the endogenous estrogen receptor-α in GBM cells.